Mamoru Moritani

The Iyo Bank Ltd. engages in the provision of banking and leasing services. It operates through the following segments: Banking, Leasing, and Others. The Banking segment offers banking services such as deposits, loans, securities investments, and foreign exchange. The Leasing segment handles leasing business through its subsidiary. The Others segment includes information processing contract, software development, and securities businesses. The company was founded on March 15, 1878 and is headquartered in Matsuyama, Japan.

JFE Shoji Corp. engages in the import, export, and domestic and foreign trade of steel products and steel raw materials. It provides iron ores, coals, ferrous alloys, steel scraps, steel plates, and steel pipes. It also deals with ship, food, and electronics businesses. The company was founded on January 5, 1954 and is headquartered in Tokyo, Japan.

Morishita Co., Ltd. is engaged in the planning, development, import, manufacture and sales of pillows, cushions, rattan products, covers, other beddings and interior products. The company was founded in October 1953 and is headquartered in Osaka, Japan.

Immunas Pharma, Inc. develops anti-cancer antibody medicines. The company is based in Kawasaki, Japan. Immunas Pharma was acquired by OncoTherapy Science, Inc. on September 30, 2007 for $0.43 million.

Part of Eli Lilly & Co., Eli Lilly Japan KK is a Japanese company that manufactures and trades pharmaceutical products. The company is based in Kobe, Japan.

INPEX Idemitsu Norge AS engages in exploration, development and production of crude oil and natural gas. The company was founded on September 25, 1989 and is headquartered in Oslo, Norway.

Megakaryon Corp. operates as an pluripotent stem cells research laboratory. It produce platelets and red blood cells from iPS cell lines, and to develop blood products that do not depend on blood donations. The firm specializes in development of technologies to produce and store induced pluripotent stem cell derived human T cells. Megakaryon was founded by Genjiro Miwa on September 9, 2011 and is headquartered in Kyoto, Japan.

Junten Bio Co. Ltd. is a Japanese company founded in 2018 that engages in research and development of cell and regenerative medicines. The company is based in Chuo-ku, Japan.